Clinical Trial Update: Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Alogliptin Phase 4 trial in Indian participants with type 2 diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: WITHDRAWN